These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25891257)

  • 1. Influence of pH and temperature on ziconotide stability in intrathecal analgesic admixtures in implantable pumps and syringes.
    Bazin C; Poirier AL; Dupoiron D
    Int J Pharm; 2015 Jun; 487(1-2):285-91. PubMed ID: 25891257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia.
    Robert J; Sorrieul J; Rossignol E; Beaussart H; Kieffer H; Folliard C; Dupoiron D; Devys C
    Int J Pharm Compd; 2017; 21(4):347-351. PubMed ID: 28719378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps.
    Dupoiron D; Richard H; Chabert-Desnot V; Devys C; Leynia P; Boisdron-Celle M
    Neuromodulation; 2014 Jul; 17(5):472-82; discussion 482. PubMed ID: 24512055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration.
    Robert J; Sorrieul J; Dupoiron D; Jubier-Hamon S; Bienfait F; Visbecq A; Devys C
    Neuromodulation; 2023 Aug; 26(6):1179-1194. PubMed ID: 35088750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for Prospective Assays of Intrathecal Mixtures Including Morphine, Ropivacaine and Ziconotide: Prevention of Adverse Events and Feasibility in Clinical Practice.
    Dupoiron D; Devys C; Bazin C; Folliard C; Lebrec N; Boré F; Dubois PY; Kieffer H
    Pain Physician; 2015; 18(4):349-57. PubMed ID: 26218938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration.
    Shields DE; Aclan J; Szatkowski A
    Int J Pharm Compd; 2008; 12(6):553-7. PubMed ID: 23969933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability Study of Admixtures Combining Ziconotide With Morphine or Sufentanil in Polypropylene Syringes.
    Sorrieul J; Robert J; Dupoiron D; Devys C
    Neuromodulation; 2021 Oct; 24(7):1145-1156. PubMed ID: 33095956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical Stability Study of the Morphine-Bupivacaine-Ziconotide Association.
    Sorrieul J; Robert J; Blanchet A; Gouju J; Bienfait F; Hamon SJ; Dupoiron D; Devys C
    Neuromodulation; 2024 Jan; ():. PubMed ID: 38300172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration.
    Shields DE; Aclan J; Szatkowski A
    Int J Pharm Compd; 2008; 12(5):463-6. PubMed ID: 23969873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Stability of Admixtures Combining Ziconotide with Morphine or Hydromorphone During Simul ated Intrathecal Administration.
    Shields D; Montenegro R; Ragusa M
    Neuromodulation; 2005 Oct; 8(4):257-63. PubMed ID: 22151554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and compatibility of drug mixtures in an implantable infusion system.
    Bianchi F; Ginggen A; Tardy Y
    Anaesthesia; 2008 Sep; 63(9):972-8. PubMed ID: 18699872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Morphine Sulfate-Clonidine and Sufentanil-Clonidine Mixtures.
    Sorrieul J; Robert J; Vincent L; Andre M; Bourcier B; Bienfait F; Hamon SJ; Dupoiron D; Devys C
    Neuromodulation; 2023 Aug; 26(6):1195-1207. PubMed ID: 36038481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system.
    Hildebrand KR; Elsberry DD; Hassenbusch SJ
    J Pain Symptom Manage; 2003 May; 25(5):464-71. PubMed ID: 12727045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stability of morphine hydrochloride in 0.9% NaCl infusion polyolefin bags after freeze-thaw treatment and in polypropylene syringes at 5 degrees C + 3 degrees C.
    Hecq JD; Godet M; Gillet P; Jamart J; Galanti L
    Int J Pharm Compd; 2014; 18(1):78-82. PubMed ID: 24881344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
    Shields D; Montenegro R
    Neuromodulation; 2007 Oct; 10 Suppl 1():6-11. PubMed ID: 22150946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system.
    Classen AM; Wimbish GH; Kupiec TC
    J Pain Symptom Manage; 2004 Dec; 28(6):603-11. PubMed ID: 15589086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration.
    Shields D; Montenegro R; Aclan J
    Neuromodulation; 2007 Oct; 10 Suppl 1():12-7. PubMed ID: 22150947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Intrathecal Pumps in Nonmalignant Pain.
    Ginalis EE; Ali S; Mammis A
    Neurosurg Clin N Am; 2022 Jul; 33(3):305-309. PubMed ID: 35718400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
    Wallace MS
    Expert Rev Neurother; 2006 Oct; 6(10):1423-8. PubMed ID: 17078783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aseptic arachnoiditis in a patient treated with intrathecal morphine infusion: symptom resolution on switch to ziconotide.
    Codipietro L; Maino P
    Neuromodulation; 2015 Apr; 18(3):217-20; discussion 220. PubMed ID: 24945709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.